Closing Thought

Mar 01, 2009
Applied Clinical Trials
By Applied Clinical Trials Editors
A clinical trials professional with personal experience as a trial subject discusses the purpose and importance of following protocol.
Feb 01, 2009
Applied Clinical Trials
By Applied Clinical Trials Editors
Ways to ensure the transition between vendors is as smooth as possible for everyone involved.
Jan 01, 2009
Applied Clinical Trials
By Applied Clinical Trials Editors
As patient recruiters and sponsors face low recruitment numbers, they must look beyond global trials to find a solution.
Nov 01, 2008
Applied Clinical Trials
By Applied Clinical Trials Editors
The need for collaboration between the various disciplines and stakeholders is becoming crucial.
Oct 01, 2008
Applied Clinical Trials
By Applied Clinical Trials Editors
A purely empirical approach to drug development may allow for evaluation of the overt factors that impact the balance of benefit and risk, but it will never uncover all potential scenarios for which companies are now being held accountable.
Sep 01, 2008
Applied Clinical Trials
By Applied Clinical Trials Editors
Finding new ways to design and conduct clinical trials in order to prevent Phase III failures.
Aug 01, 2008
Applied Clinical Trials
REMS are new only in name. The basic concept has long been central to drug regulation.
Jul 01, 2008
Applied Clinical Trials
By Applied Clinical Trials Editors
The impact of proactive subject recruitment planning.
Jun 01, 2008
Applied Clinical Trials
By Applied Clinical Trials Editors
Chris Bode, PhD, vice president of corporate development for Absorption Systems, explains the impact of in vitro models relative to the Critical Path Initiative.
May 01, 2008
Applied Clinical Trials
By Applied Clinical Trials Editors
Norbert Clemens, MD, head of clinical development for CRS Clinical Research Services, explains that EDC is more than just technology; it is indeed the new way of thinking about clinical research.
native1_300x100
lorem ipsum